rs587783194

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2

The NM_139058.3(ARX):​c.211A>T​(p.Ser71Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000863 in 927,345 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S71R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000054 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.0000025 ( 0 hom. 0 hem. )

Consequence

ARX
NM_139058.3 missense

Scores

2
3
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 1.25

Publications

0 publications found
Variant links:
Genes affected
ARX (HGNC:18060): (aristaless related homeobox) This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is thought to be involved in CNS development. Expansion of a polyalanine tract and other mutations in this gene cause X-linked cognitive disability and epilepsy. [provided by RefSeq, Jul 2016]
ARX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • intellectual disability, X-linked, with or without seizures, ARX-related
    Inheritance: XL Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, G2P
  • Partington syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked lissencephaly with abnormal genitalia
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • corpus callosum agenesis-abnormal genitalia syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile epileptic-dyskinetic encephalopathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked spasticity-intellectual disability-epilepsy syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3215518).
BP6
Variant X-25013784-T-A is Benign according to our data. Variant chrX-25013784-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 157751.
BS2
High AC in GnomAd4 at 6 AD,XL gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARXNM_139058.3 linkc.211A>T p.Ser71Cys missense_variant Exon 2 of 5 ENST00000379044.5 NP_620689.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARXENST00000379044.5 linkc.211A>T p.Ser71Cys missense_variant Exon 2 of 5 1 NM_139058.3 ENSP00000368332.4

Frequencies

GnomAD3 genomes
AF:
0.0000537
AC:
6
AN:
111656
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000114
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000245
AC:
2
AN:
815689
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
249017
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
17659
American (AMR)
AF:
0.00
AC:
0
AN:
6153
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
10247
East Asian (EAS)
AF:
0.00
AC:
0
AN:
19996
South Asian (SAS)
AF:
0.00
AC:
0
AN:
14100
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
15560
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2001
European-Non Finnish (NFE)
AF:
0.00000287
AC:
2
AN:
696901
Other (OTH)
AF:
0.00
AC:
0
AN:
33072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.650
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000537
AC:
6
AN:
111656
Hom.:
0
Cov.:
23
AF XY:
0.0000589
AC XY:
2
AN XY:
33972
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30935
American (AMR)
AF:
0.00
AC:
0
AN:
10795
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2644
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3476
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2766
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5908
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
233
European-Non Finnish (NFE)
AF:
0.000114
AC:
6
AN:
52696
Other (OTH)
AF:
0.00
AC:
0
AN:
1525
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Mar 28, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.211A>T (p.S71C) alteration is located in exon 2 (coding exon 2) of the ARX gene. This alteration results from a A to T substitution at nucleotide position 211, causing the serine (S) at amino acid position 71 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

ARX-related disorder Uncertain:1
Dec 20, 2023
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The ARX c.211A>T variant is predicted to result in the amino acid substitution p.Ser71Cys. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Intellectual disability, X-linked, with or without seizures, ARX-related;C3463992:Developmental and epileptic encephalopathy, 1 Uncertain:1
Aug 24, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces serine with cysteine at codon 71 of the ARX protein (p.Ser71Cys). The serine residue is weakly conserved and there is a moderate physicochemical difference between serine and cysteine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has not been reported in the literature in individuals affected with ARX-related conditions. ClinVar contains an entry for this variant (Variation ID: 157751). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Benign:1
Feb 04, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jan 28, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.014
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
23
DANN
Benign
0.95
DEOGEN2
Benign
0.17
T
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.48
T
M_CAP
Pathogenic
0.98
D
MetaRNN
Benign
0.32
T
MetaSVM
Benign
-0.32
T
MutationAssessor
Benign
1.2
L
PhyloP100
1.3
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-0.96
N
REVEL
Benign
0.24
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.059
T
Polyphen
0.98
D
Vest4
0.28
MutPred
0.23
Loss of phosphorylation at S71 (P = 0.0179);
MVP
0.89
MPC
1.1
ClinPred
0.50
T
GERP RS
2.8
Varity_R
0.22
gMVP
0.20
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587783194; hg19: chrX-25031901; API